- Home
- IMAB vs CODA Comparison
IMAB vs CODA Comparison
Compare IMAB & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- CODA
- Stock Information
- Founded
- IMAB 2014
- CODA 1994
- Country
- IMAB United States
- CODA United States
- Employees
- IMAB N/A
- CODA N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- CODA Industrial Machinery/Components
- Sector
- IMAB Health Care
- CODA Industrials
- Exchange
- IMAB Nasdaq
- CODA Nasdaq
- Market Cap
- IMAB 200.9M
- CODA 88.7M
- IPO Year
- IMAB 2020
- CODA N/A
- Fundamental
- Price
- IMAB $2.30
- CODA $8.11
- Analyst Decision
- IMAB Strong Buy
- CODA Strong Buy
- Analyst Count
- IMAB 2
- CODA 1
- Target Price
- IMAB $6.00
- CODA $11.00
- AVG Volume (30 Days)
- IMAB 766.4K
- CODA 56.4K
- Earning Date
- IMAB 05-15-2025
- CODA 06-16-2025
- Dividend Yield
- IMAB N/A
- CODA N/A
- EPS Growth
- IMAB N/A
- CODA 21.86
- EPS
- IMAB N/A
- CODA 0.30
- Revenue
- IMAB N/A
- CODA $22,758,966.00
- Revenue This Year
- IMAB N/A
- CODA $11.64
- Revenue Next Year
- IMAB N/A
- CODA $14.53
- P/E Ratio
- IMAB N/A
- CODA $26.63
- Revenue Growth
- IMAB N/A
- CODA 24.78
- 52 Week Low
- IMAB $0.60
- CODA $5.76
- 52 Week High
- IMAB $3.08
- CODA $9.89
- Technical
- Relative Strength Index (RSI)
- IMAB 53.81
- CODA 57.53
- Support Level
- IMAB $2.02
- CODA $7.78
- Resistance Level
- IMAB $2.95
- CODA $8.56
- Average True Range (ATR)
- IMAB 0.33
- CODA 0.45
- MACD
- IMAB -0.08
- CODA 0.00
- Stochastic Oscillator
- IMAB 31.05
- CODA 56.09
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.